Oral sodium phosphate and polyethylene glycol in patients with chronic constipation:a comparison between two colonic cleansing regimens

Hui-min CHEN,Xiao-bo LI,Zhi-zheng GE

DOI: https://doi.org/10.3760/cma.j.issn.1007-5232.2008.09.006

2008-01-01

Abstract:Objective To determine the efficacy, tolerance and safety of oral sodium phosphate compared with polyethylene glycol in patients with chronic constipation. Methods From May 2007 to October 2007, 100 patients with chronic constipation referred for colonoscopy were prospectively randomized into two groups. Group A （n =49） received sodium phosphate before colonoscopy, while group B （n = 51 ） received polyethylene glycol. Patients with intestinal stenosis found by colonoscopy were excluded. The quality of preparation was assessed by the endoscopist who was blinded to the type of colon cleansing, and the defecation frequency after taking the medicine of each patient was recorded. The blood pressure （BP） and heart rate （HR） of every patient were monitored before and after the preparation, laboratory examinations including hematocrit, serum phosphorous, serum calcium, blood urea nitrogen, and serum creatinine were per- formed. A questionnaire was used to assess side effects and patients tolerance to the regimen. Results Two patients in group A were excluded because tumor induced stenosis was detected with colonoscopy. The baseline parameters of age, sex, endoscopic diagnosis or constipation were homogeneously distributed in two groups. Compared with group B, patients in group A had better quality of colon preparation （0. 96 ＋ 0. 07 vs. 1.52±0. 08, P =0. 0411 ）, less intestinal bubble （ 1.04±. 08 vs. 1.48 ±0. 09, P = 0. 0314）, and higher defecation frequency （8.90 ±0. 97 vs. 7.69±0. 93, P =0. 219）. There was no significant difference in the scores of each regimeng taste and the willing rates of repeating the assigned preparation, while statistically more patients completed the sodium phosphate preparation （98% vs. 90% , P = 0. 0335 ）. There were no significant differences in terms of patients＇BP, HR, the scores and the frequencies of side effects between two regimens. Transient hyperphosphatemia was noted in 4 patients in group A, but neither clinical symptoms nor hypocalcemia was observed. Conclusion For patients with chronic constipation, sodium phosphate is just as tolerated and safe as a standard polyethylene glycol regimen and provides better quality of preparation of the bowel for colonoscopy. Key words: Constipation ; Bowel preparation; Sodium phosphate; Polyethylene glycol